Literature DB >> 33956308

Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment.

Yashika Chugh1, Maria De Francesco2, Shankar Prinja3.   

Abstract

OBJECTIVES: The objective of this systematic review was to review the recommendations for the conduct of a budget impact analysis in national or organisational guidelines globally.
METHODS: We searched several databases including MELDINE, EMBASE, The Cochrane Library, National Guideline Clearinghouse, HTA Database (International Network of Agencies for Health Technology Assessment), Econlit and IDEAS Database (RePEc, Research Papers in Economics). The OVID platform was used to run the search in all databases simultaneously. In addition, a search of the grey literature was also conducted. The timeframe was set from 2000 to 2020 with language of publication restricted to English.
RESULTS: A total of 13 publications were selected. All the countries where financing of health is predominantly tax funded with public provisioning recommend a healthcare payer (government) perspective. However, countries where a healthcare payer includes a mix of federal government, communities, hospital authorities and patient communities recommend a complementary analysis with a wider societal perspective. While four guidelines prefer a simple cost calculator for costing, the rest rely on a decision modelling approach. None of the guidelines recommend discounting except the Polish guidelines, which recommend discounting at 5%. Only two countries, Belgium and Poland, mention that indirect costs, if significant, should be included in addition to direct costs.
CONCLUSIONS: The comparative cross-country analysis shows that a standard set of recommendations cannot be directly useful for all as there are contextual differences. Thus, budget impact analysis guidelines must be carefully contextualised in the policy environment of a country so as to reflect the dynamics of health systems.

Entities:  

Year:  2021        PMID: 33956308     DOI: 10.1007/s40258-021-00652-6

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  1 in total

1.  Budget impact analysis.

Authors:  Pattara Leelahavarong
Journal:  J Med Assoc Thai       Date:  2014-05
  1 in total
  2 in total

1.  Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study.

Authors:  Yue Ma; Yuxin Li; Aixia Ma; Hongchao Li
Journal:  Front Public Health       Date:  2021-11-05

2.  National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India.

Authors:  Shankar Prinja; Yashika Chugh; Kavitha Rajsekar; V R Muraleedharan
Journal:  Appl Health Econ Health Policy       Date:  2021-06-29       Impact factor: 2.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.